Predictors of actual five-year survival and recurrence after pancreatoduodenectomy for ampullary adenocarcinoma: results from an international multicentre retrospective cohort study.
Name:
Publisher version
View Source
Access full-text PDFOpen Access
View Source
Check access options
Check access options
Author
Russell, Thomas BLabib, Peter L
Denson, Jemimah
Ausania, Fabio
Pando, Elizabeth
Roberts, Keith J
Kausar, Ambareen
Mavroeidis, Vasileios K
Thomasset, Sarah C
Frampton, Adam E
Lykoudis, Pavlos
Maglione, Manuel
Alhaboob, Nassir
Bari, Hassaan
Smith, Andrew M
Spalding, Duncan
Srinivasan, Parthi
Davidson, Brian R
Bhogal, Ricky H
Croagh, Daniel
Dominguez, Ismael
Thakkar, Rohan
Gomez, Dhanny
Silva, Michael A
Lapolla, Pierfrancesco
Mingoli, Andrea
Porcu, Alberto
Shah, Nehal S
Hamady, Zaed Z R
Al-Sarrieh, Bilal
Serrablo, Alejandro
Aroori, Somaiah
Marangoni, Gabriele
Publication date
2023-03-30
Metadata
Show full item recordAbstract
Background: Pancreatoduodenectomy (PD) is recommended in fit patients with a resectable ampullary adenocarcinoma (AA). We aimed to identify predictors of five-year recurrence/survival.Citation
HPB (Oxford) . 2023 Jul;25(7):788-797Type
ArticlePMID
37149485Journal
HPBPublisher
Elsevierae974a485f413a2113503eed53cd6c53
10.1016/j.hpb.2023.03.010